Ken Griffin Addex Therapeutics Ltd. Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.68 - $2.19 $4,760 - $15,330	-7,000 Reduced 16.91%	34,385 $32,000
Q4 2022 Feb 14, 2023	BUY	$0.55 - $0.85 $15,720 - $24,294	28,582 Added 223.24%	41,385 $26,000
Q3 2022 Nov 14, 2022	BUY	$0.78 - $1.98 $9,986 - $25,349	12,803 New	12,803 $10,000
Q1 2021 May 17, 2021	BUY	$9.82 - $14.11 $113,951 - $163,732	11,604 New	11,604 $121,000

Ticker ADXN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,204,630
Market Cap $62.4M
Description
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs includ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.